Results 11 to 20 of about 12,943 (270)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

open access: yesPathogens, 2022
Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources required for performing infusions.
Erin Kuang   +17 more
doaj   +4 more sources

Fruit-frugivore dependencies are important in Ebolavirus outbreaks in Sub-Saharan Africa. [PDF]

open access: yesEcography
Ebolaviruses have the ability to infect a wide variety of species, with many African mammals potentially serving either as primary reservoirs or secondary amplifying hosts.
Sundaram M   +8 more
europepmc   +3 more sources

Glycan shield of the ebolavirus envelope glycoprotein GP [PDF]

open access: yesCommunications Biology, 2022
The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response. GP is heavily glycosylated with up to 17 N-linked sites, numerous O-linked glycans in its disordered mucin-like domain
W. Peng   +9 more
semanticscholar   +8 more sources

Ebolavirus evolution and emergence are associated with land use change

open access: hybridEcological Monographs, Volume 95, Issue 1, February 2025.
Anthropogenic land use change facilitates disease emergence by altering the interface between humans and pathogen reservoirs and is hypothesized to drive pathogen evolution.
Christian E. Lange   +8 more
semanticscholar   +3 more sources

Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo.

open access: yesPLoS Neglected Tropical Diseases, 2022
Although multiple antigenically distinct ebolavirus species can cause human disease, previous serosurveys focused on only Zaire ebolavirus (EBOV). Thus, the extent of reactivity or exposure to other ebolaviruses, and which sociodemographic factors are ...
Kelly C L Shaffer   +18 more
doaj   +2 more sources

Traits, phylogeny and host cell receptors predict Ebolavirus host status among African mammals.

open access: yesPLoS Neglected Tropical Diseases, 2022
We explore how animal host traits, phylogenetic identity and cell receptor sequences relate to infection status and mortality from ebolaviruses. We gathered exhaustive databases of mortality from Ebolavirus after exposure and infection status based on ...
Mekala Sundaram   +4 more
doaj   +2 more sources

Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification

open access: yesJournal of Medical Virology, Volume 96, Issue 6, June 2024.
Ebolavirus disease (EVD) is an often‐lethal disease caused by the genus Ebolavirus (EBOV). Although vaccines are being developed and recently used, outbreak control still relies on a combination of various factors, including rapid identification of EVD ...
Arianna Ceruti   +8 more
semanticscholar   +2 more sources

Bombali Ebolavirus in Mops condylurus Bats (Molossidae), Mozambique

open access: yesEmerging Infectious Diseases, 2022
We detected Bombali ebolavirus RNA in 3 free-tailed bats (Mops condylurus, Molossidae) in Mozambique. Sequencing of the large protein gene revealed 98% identity with viruses previously detected in Sierra Leone, Kenya, and Guinea.
Camille Lebarbenchon   +9 more
doaj   +2 more sources

Serological evidence of ebolavirus infection in bats, China [PDF]

open access: yesVirology Journal, 2012
Background The genus Ebolavirus of the family Filoviridae currently consists of five species. All species, with the exception of Reston ebolavirus, have been found in Africa and caused severe human diseases.
Yuan Junfa   +5 more
doaj   +4 more sources

Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.

open access: yesPLoS Pathogens
Monoclonal antibodies (mAbs) are an important class of antiviral therapeutics. MAbs are highly selective, well tolerated, and have long in vivo half-life as well as the capacity to induce immune-mediated virus clearance.
Ariel S Wirchnianski   +21 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy